Dmitry Guschin

Centre National de la Recherche Scientifique — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

35h-index10.0kcitations56works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CRISPR and Genetic Engineering(21), Genomics and Chromatin Dynamics(10), Advanced biosensing and bioanalysis techniques(8), Cytokine Signaling Pathways and Interactions(8), RNA Interference and Gene Delivery(7)

Publications56 total

Identification of PKN2 and MOB4 as Coordinators of Collective Cell Migration
Advanced Science·2025Open Access
Circulating Tumor DNA in Prostate Cancer: A Dual Perspective on Early Detection and Advanced Disease Management
Cancers·2025· 2 citedOpen Access
Modern approaches to engineering human reporter cell lines using CRISPR within Safe Harbor loci and endogenous genes
Critical Reviews in Biotechnology·2025
Vinculin–Arp2/3 interaction inhibits branched actin assembly to control migration and proliferation
Life Science Alliance·2024· 9 citedOpen Access
Vinculin-Arp2/3 Interaction Inhibits Branched Actin Assembly to Control Cell Migration and Cell Cycle Progression
2023Open Access
On quasi-arithmeticity of hyperbolic gluings
arXiv (Cornell University)·2023· 1 citedOpen Access
BRCA Mutations—The Achilles Heel of Breast, Ovarian and Other Epithelial Cancers
International Journal of Molecular Sciences·2023· 23 citedOpen Access
BRCA Mutations: The Achilles Heel of Breast, Ovarian and Other Epithelial Cancers
Preprints.org·2023· 9 citedOpen Access
3129 – ROLE OF MICROGLIA IN TP53/IDH1 MUTANT GLIOMAS DEVELOPMENT.
Experimental Hematology·2020
CRISPR/Cas-Systems: characteristics and possibilities of use for editing bacterial genomes
Bacteriology·2020
Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington’s disease
Nature Medicine·2019· 212 cited
Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins
Viruses·2017· 58 citedOpen Access
37. Towards Clinical Translation of Hematopoietic Stem Cell Gene Editing for the Correction of SCID-X1 Mutations
Molecular Therapy·2016Open Access
Clinical Scale Zinc Finger Nuclease-mediated Gene Editing of PD-1 in Tumor Infiltrating Lymphocytes for the Treatment of Metastatic Melanoma
Molecular Therapy·2015· 111 citedOpen Access
185. Targeted Correction and Restored Function of CFTR Gene in Cystic Fibrosis Induced Pluripotent Stem Cells
Molecular Therapy·2015· 3 citedOpen Access
686. Gene Correction of IL2RG in Human Hematopoietic Stem and Progenitor Cells
Molecular Therapy·2015Open Access
Improved specificity of TALE-based genome editing using an expanded RVD repertoire
Nature Methods·2015· 93 cited
Targeted Correction and Restored Function of the CFTR Gene in Cystic Fibrosis Induced Pluripotent Stem Cells
Stem Cell Reports·2015· 196 citedOpen Access
Targeted Gene Modification In Hematopoietic Stem Cells: A Potential Treatment For Thalassemia and Sickle Cell Anemia
Blood·2013
Translating dosage compensation to trisomy 21
Nature·2013· 332 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Philip D. Gregory(20), Edward J. Rebar(15), Jeffrey C. Miller(11), Michael C. Holmes(10), Fyodor D. Urnov(10), Alan P. Wolffe(9), Jianbin Wang(7), David E. Paschon(7), James Briscoe(5), Bruce A. Witthuhn(5), Ya-Li Lee(4), Adam James Waite(4), Josée Laganière(4), Diane Watling(4), Neil C. Rogers(4), George R. Stark(4), A.D. Mirzabekov(4), Ian M. Kerr(4), Irina Ankoudinova(4), Igor Rupniewski(3)